Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid Leukemia (AML) in Complete Remission

NCT01757535 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

472

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia, Myeloid, Acute

Interventions

DRUG: Oral Azacitidine
DRUG: Placebo

Sponsor

Celgene